한국어/조선말   日本語   汉语 汉语  漢語 漢語

Home  |  Speakers  |  Agenda  |  Venue  |  Delegates  |  Sponsors  |  Media  |  Register









Following on from the success of the inaugural meeting which attracted over 150 key senior attendees, Global Engage is pleased to announce the 2nd Precision Medicine Congress which will be held on 14-15
September 2015 in London, UK.  The meeting is part of our successful Drug Discovery series which includes innovative meetings on Digital Health, Digital Pathology, Human Microbiome, Synthetic Biology, qPCR / dPCR, & Biologics among others. www.globalengage.co.uk/events/

Recent advancements in the biomarker, CDx genomic and big data space have meant that some of the fundamental challenges of precision medicine are being realised.  The potential for personalized medicine and therefore the possibility of delivering superior outcomes for patients is in reach.  There is, however, a lot more to do.  Alongside the continued developments in science as well as improvements in clinical trial design, support mechanisms such as market access /reimbursement/ regulatory strategies need to be further developed.  Continued work by all stakeholders is therefore vital for success.

"Since The Human Genome Project transformed our approach to medicine and ushered in a revolution in healthcare, we have reached the point at which the cost of sequencing an individual genome will be affordable. This combined with major advances in tools to exploit "Big Data", technology and patient-activated social networks is set to usher in an era of P4 Medicine [...] 

I hope that you will be able to join me in London to debate the strategies and review the developments that will be needed to deliver P4 medicine for patients around the world.
"


Lee HoodLeroy Hood
President
Institute of Systems Biology, USA

(Keynote presentation, day one)


The congress has been purposely designed for a variety of audiences from drug and DX developers, payers, healthcare providers, academics to technology solution providers.

Attracting experts working in all areas of precision and personalised medicine such as biomarkers, CDx, translational medicine, clinical trials, genomics, NGS, bioinformatics and health economics, this two day interactive meeting will provide you the opportunity to take home cutting edge strategies, case study examples and methods to allow you to both implement and take the vital next steps in delivering precision medicine.  This will be achieved through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, expert led case study presentations and interactive Q&A panel discussions examining topics during four separate tracks covering the areas below.

Day One, Stream One – Strategies & Technologies to Enable Successful Implementation of Precision Medicine
Day One, Stream Two – Precision Medicine Therapeutic Case Studies
Day Two, Stream One – Biomarker & Companion Diagnostics Development to Deliver Precision Medicine
Day Two, Stream Two – Integrating Personal Genomics, Big Data and Bioinformatics

The event is currently in production. For a more detailed synopsis or to download last year’s final conference agenda, please visit the agenda page.



Advisory Board
Slava AkmaevSlava Akmaev
Chief Analytics Officer, Berg



Michael E. Burczynski
Executive Director, Biomarker Technologies, Clinical Biomarkers, ECTR, Bristol-Myers Squibb

John
                          FergusonJohn Ferguson
Global Head, Medical Safety & Pharmacovigilance, Novartis Vaccines & Diagnostics

Omar LaterzaOmar Laterza
Director of Immunoassay & Mass Spectrometry, Molecular Biomarkers and Diagnostics Laboratory, Merck

Alain van GoolAlain van Gool
Professor, Head Biomarkers in Personalized Healthcare, TNO, Radboud University Medical Center

Martina KaufmannMartina Kaufmann
Managing Director, Martina Kaufmann Strategic Consulting

Peter SmithPeter Smith
VP, Drug Discovery Biology, H3 Biomedicine


Morten SogaardMorten Sogaard
Executive Director and Head, Biotechnology & Precision Medicine External R&D Innovation, Pfizer

Weida TongWeida Tong
Director, Division of Bioinformatics and Biostatistics, NCTR/FDA


Miro VenturiMiro Venturi
Site Head - Oncology Biomarkers, Roche



Xuemei Zhao
Principal Scientist, Molecular Biomarkers and Diagnostics Laboratory, Merck



Supported by:
    


Get the latest news and updates:

 

 
 
 
We hate spam and will never sell your details. 






Newsletter


Register
                  Now

Sponsors

Platinum Sponsors





Gold Sponsors





Silver Sponsors










Other Sponsors



















 


For further information please contact;

Steve Hambrook

Conference Director

steve@globalengage.co.uk



About Global Engage  |  T&Cs  |  Agenda  |  Testimonials  |  Register



Copyright:  Global Engage Ltd.   Registered in England.  No: 6950636